摘要:我们在临床实践中观察到低剂量的CAG预激方案对难治或复发急性淋巴细胞白血病(ALL)尤其是T-ALL显示出了较好的疗效.考虑到该方案最初是为髓系白血病设计,且其主要原理是G-CSF通过其受体(G-CSFR)介导,驱动G0期白血病细胞进入增殖周期进而增强化疗药物的杀伤作用.我们推测G-CSF以类似的作用方式对ALL细胞发挥作用.
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
High Technology Letters Particuology Tsinghua Science and Technology Journal of Integrative Plant Biology Journal of Integrative Agriculture Current Zoology Acta Oceanologica Sinica Chinese Journal of Oceanology and Limnology Journal of Energy Chemistry Acta Geologica Sinica China Petroleum Processing Petrochemical Technology Acta Metallurgica Sinica